Portal hypertensive enteropathy

doi:10.3877/cma.j.issn.2095-7157.2021.01.006

Abstract

Abstract:

Portal hypertension is a group of symptoms caused by the continuous increase of portal pressure. The most common manifestation is gastrointestinal bleeding, especially esophageal and gastric varices bleeding. With the development of small intestine examination, especially capsule endoscopy and double balloon enteroscopy, the portal hypertension features in the small intestine was defined as portal hypertension enterophy(PHE), which could be a source of gastrointestinal bleeding. Therefore, in patients with gastrointestinal bleeding, the examination of PHE should not be ignored when there is no varicose vein in the stomach or esophagus.

Key words: Portal hypertension, Small intestine, Portal hypertensive enteropathy, Gastrointestinal bleeding

Dandan Song, Ningli Chai. Portal hypertensive enteropathy[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(01): 33-36.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2021.01.006

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2021/V08/I01/33

References 35

[1]	Thiruvengadam R, Gostout CJ.Congestive gastroenteropathy-an extension of nonvariceal upper gastrointestinal bleeding in portal hypertension[J]. Gastrointest Endosc, 1989, 35(4): 504-507.
[2]	De Palma GD, Rega M, Masone S, et al.Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study[J]. Gastrointest Endosc, 2005, 62(4): 529-534.
[3]	Aoyama T, Oka S, Aikata H, et al.Small bowel abnormalities in patients with compensated liver cirrhosis[J]. Dig Dis Sci, 2013, 58(5): 1390-1396.
[4]	Higaki N, Matsui H, Imaoka H, et al.Characteristic endoscopic features of portal hypertensive enteropathy[J]. J Gastroenterol, 2008, 43(5): 327-331.
[5]	Kodama M, Uto H, Numata M, et al.Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy[J]. J Gastroenterol, 2008, 43(8): 589-596.
[6]	Abdelaal UM, Morita E, Nouda S, et al.Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact？[J]. J Clin Biochem Nutr, 2010, 47(1): 37-44.
[7]	Huang WH, Hsu C, Chao YC.Colonic polypoid lesions: an unusual endoscopic presentation of portal hypertensive colonopathy[J]. Gastrointest Endosc, 1999, 50(2): 283-285.
[8]	Zeitoun JD, Chryssostalis A, Terris B, et al.Portal hypertensive duodenal polyp- A case report[J]. World J Gastroenterol, 2007, 13(9): 1451-1452.
[9]	Devadason D, Murphy MS, Brown R, et al.Duodenal capillary hemangiomatous polyps: a novel manifestation of extrahepatic portal hypertension？[J]. J Pediatr Gastroenterol Nutr, 2007, 45(1): 114-116.
[10]	Tang SJ, Jensen D, Gralnek IF, et al.Portal hypertensive enteropathy in a patient with polycystic liver disease: a unique endoscopic finding[J]. Gastrointest Endosc, 2002, 56(6): 924-926.
[11]	Sawada K, Ohtake T, Ueno N, et al.Multiple portal hypertensive polyps of the jejunum accompanied by anemia of unknown origin[J]. Gastrointest Endosc, 2011, 73(1): 179-182.
[12]	Tang SJ.Portal hypertensive polypoid enteropathy[J]. Gastrointest Endosc, 2011, 73(6): 1332.
[13]	Laskaratos FM, Toumpanakis C, Clark I, et al.Diagnosis of polypoid portal hypertensive enteropathy due to superior mesenteric vein thrombosis by capsule endoscopy and double-balloon enteroscopy[J]. Endoscopy, 2014, 46(Suppl 1): E592-E593.
[14]	Jeon SR, Kim JO.Capsule Endoscopy for Portal Hypertensive Enteropathy[J]. Gastroenterol Res Pract, 2016, 2016: 8501394.
[15]	Al-Azzawi Y, Spaho L, Mahmoud M, et al.Video Capsule Endoscopy in the Assessment of Portal Hypertensive Enteropathy[J]. Int J Hepatol, 2018, 2018: 5109689-5109689.
[16]	Mekaroonkamol P, Cohen R, Chawla S. Portal hypertensive enteropathy[J]. World J Hepatol, 2015, 7(2): 127-138.
[17]	Rondonotti E, Villa F, Signorelli C, et al.Portal Hypertensive Enteropathy[J]. Gastrointest Endosc Clin N Am, 2006, 16(2): 277-286.
[18]	Jeon SR, Kim JO, Kim JB, et al.Portal hypertensive enteropathy diagnosed by capsule endoscopy in cirrhotic patients: a nationwide multicenter study[J]. Dig Dis Sci, 2014, 59(5): 1036-1041.
[19]	Akyuz F, Pinarbasi B, Ermis F, et al.Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients？[J]. Scand J Gastroenterol, 2010, 45(12): 1497-1502.
[20]	Figueiredo P, Almeida N, Lerias C, et al.Effect of portal hypertension in the small bowel: an endoscopic approach[J]. Dig Dis Sci, 2008, 53(8): 2144-2150.
[21]	Canlas KR, Dobozi BM, Lin S, et al.Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia[J]. J Clin Gastroenterol, 2008, 42(7): 844-848.
[22]	Kodama M, Uto H, Numata M, et al.Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy[J]. J Gastroenterol, 2008, 43(5): 589-596.
[23]	Goulas S, Triantafyllidou K, Karagiannis S, et al.Capsule endoscopy in the investigation of patients with portal hypertension and anemia[J]. Can J Gastroenterol, 2008, 22(5): 469-474.
[24]	Misra SP, Dwivedi M, Misra V, et al.Ileal varices and portal hypertensive ileopathy in patients with cirrhosis and portal hypertension[J]. Gastrointest Endosc, 2004, 60(5): 778-783.
[25]	Alessandro R, Marco P, Antonio O, et al.Capsule Endoscopy in Cirrhotic Patients: Prevalence and Spectrum of Small Bowel Lesions[J]. Gastrointest Endosc, 2005, 61(5): AB158.
[26]	Kunihara S, Oka S, Tanaka S, et al. Predictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients with Liver Cirrhosis: A Capsule Endoscopy Study[J]. Digestion, 2018, 98(1): 33-40.
[27]	Aoyama T, Oka S, Aikata H, et al.Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis[J]. J Gastroenterol Hepatol, 2015, 30(1): 124-130.
[28]	Zwiebel WJ, Mountford RA, Halliwell MJ, et al.Splanchnic blood flow in patients with cirrhosis and portal hypertension: investigation with duplex Doppler US[J]. Radiology, 1995, 194(3): 802-812.
[29]	Nagral AS, Joshi AS, Bhatia SJ, et al.Congestive jejunopathy in portal hypertension[J]. Gut, 1993, 34(5): 694-697.
[30]	Aller MA, Arias JL, Cruz A, et al.Inflammation: a way to understanding the evolution of portal hypertension[J]. Theor Biol Med Model, 2007, 4(1): 44-69.
[31]	Galli S, Kalesnikoff J, Grimbaldeston M, et al.Mast cells as "tunable" effector and immunoregulatory cells: Recent advances[J]. Ann Rev Immunol, 2005, 23: 749-786.
[32]	Abraldes JG, Iwakiri Y, Loureiro-Silva M, et al.Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290(5): G980-G987.
[33]	Fernandez M, Mejias M, Garcia-Pras E, et al.Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats[J]. Hepatology, 2007, 46(4): 1208-1217.
[34]	Lopez-Talavera JC, Cadelina G, Olchowski J, et al.Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats[J]. Hepatology, 1996, 23(6): 1616-1621.
[35]	Jimenez-Saenz M, Romero-Vazquez J, Romero-Vazquez J, et al.Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy[J]. Dig Liver Dis, 2010, 42(3): 232-233.

Please choose a citation manager

Content to export